Hormone Study Insights

Peter discusses the complexities of a hormone replacement therapy study, highlighting the selection of an unhealthy, post-menopausal population and the exclusion of symptomatic patients. He raises concerns about the study's design and the implications for real-world applications, particularly the use of synthetic hormones derived from horse urine. This conversation sheds light on the importance of understanding trial demographics when evaluating health interventions.